Secondary Logo

Journal Logo

March 2021 - Volume 44 - Issue 3
pp: 93-130


Head and Neck


Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety

Valerio, Maria R.; Arrivas Bajardi, Eugenia; Arcara, Carmelo C.; More

American Journal of Clinical Oncology. 44(3):105-108, March 2021.


Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy

Parikh, Anish B.; Zhong, Xiaobo; Mellgard, George; More

American Journal of Clinical Oncology. 44(3):114-120, March 2021.


Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)

Santini, Daniele; Stellato, Marco; De Giorgi, Ugo; More

American Journal of Clinical Oncology. 44(3):121-125, March 2021.

Soft Tissue